# ISP-TACE Versus TACE for HCC With PVTT

> **NCT03108248** · — · COMPLETED · sponsor: **Zhongda Hospital** · enrollment: 126 (actual)

## Conditions studied

- HCC
- Portal Vein Tumor Thrombosis

## Interventions

- **DRUG:** ethiodized oil; doxorubicin;Gelfoam;
- **DEVICE:** stent; idoine-125

## Key facts

- **NCT ID:** NCT03108248
- **Lead sponsor:** Zhongda Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-01
- **Primary completion:** 2016-12-12
- **Final completion:** 2017-03-25
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2017-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03108248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03108248, "ISP-TACE Versus TACE for HCC With PVTT". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03108248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*